Research Article
Reappraisal Value of a Modified Rotational Atherectomy Technique in Contemporary Coronary Angioplasty Era
Table 1
Baseline clinical characteristics of the patients (n = 1169).
| | Characteristics | No. of patients (%) or median (IQR) |
| | Age (years) | 75 (69–81) | | Age >80 years | 375 (32.1) | | Body mass index (kg/m2) | 23.60 (21.50–26.40) | | Men | 762 (65.2) | | Current smoker | 136 (11.6) | | Diabetes mellitus | 521 (44.6) | | Hypertension | 1018 (87.1) | | Hyperlipidemia | 889 (76.0) | | Clinical diagnosis | | Stable angina | 1132 (96.8) | | Unstable angina | 35 (3.0) | | Non-STEMI | 1 (0.1) | | STEMI | 1 (0.1) | | Old myocardial infarction, | 271 (23.2) | | Previous PCI | 644 (56.8) | | Previous coronary artery bypass graft | 139 (11.9) | | Atrial fibrillation | 63 (5.4) | | Hemodialysis | 137 (11.7) | | Estimated glomerular filtration rate (ml/min·1.73 m2) | 51 (38–62) | | LVEF (%) | 65 (60–69) | | Medication at discharge | | β-blocker | 250 (21.4) | | Dual antiplatelet | 1073 (91.8) | | Statin | 644 (55.1) | | Eicosapentaenoic acid | 98 (8.4) | | Ezetimibe | 43 (3.7) | | Fibrates | 27 (2.3) | | ACEI/ARB | 583 (49.9) | | Calcium channel blocker | 691 (59.1) | | Laboratory data | | Hemoglobin (g/dL) | 12.70 (11.20–13.80) | | HDL-C (mg/dL) | 44 (36–53) | | LDL-C (mg/dL) | 91 (73–113) | | HbA1c (%) | 6 (5.60–6.60) |
|
|
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; HbA1c, hemoglobinA1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction.
|
